Camson Bio Technologies share price, trading suspended

Latest announcements

Routine notices left out.Share news and announcements

Jan 2021
- 13 Jan · Management
  Initiation of Liquidation Process & Appointment of Liquidator (opens in a new tab)
Feb 2020
- 28 Feb · Corporate Insolvency Resolution Process (CIRP)-Replacement of Interim Resolution Professional (IRP)
  This is to inform you that, Corporate Insolvency Resolution Process of Camson Bio Technologies Limited (the Corporate Debtor) commenced by the order of National Company Law Tribunal, Bengaluru .... (opens in a new tab)
- 28 Feb · Management
  Intimation of Corporate Insolvency Resolution Process (CIRP) against Camson Bio Technologies Limited and appointment of Resolution Professional. (opens in a new tab)
Nov 2019
- 12 Nov · Management
  We are informed that an Interim Resolution Professional (IRP) has been appointed till date but no one has approached us to take charge. We are not clear about anything till date. .... (opens in a new tab)
Oct 2019
- 16 Oct · Management
  With reference to the captioned matter, we wish to inform that Mr. Virendra Kumar Singh (DIN: 07226146) and Mr. Manoj Srivastava (DIN: 00513960), Independent Directors of the Company has .... (opens in a new tab)
- 16 Oct · Management
  With reference to the captioned matter, we wish to inform that Mr. Anurudh Kumar Singh (DIN: 02539344), Independent Director of the Company has resigned from his position w.e.f. 15th October, .... (opens in a new tab)

Daily closes since Jan 2015, adjusted for splits and bonuses, with the demerger of Sep 2015 reinvested. Reinvested means the value of the shares of the company that was split off is treated as put back into this share at its opening price on the ex-date.

Daily close, ₹ per share

Results

Standalone, as consolidated accounts are on record for only 3 of the last ten years; ₹ crore, the charts by years to March, the table by quarter. No standalone results on record for the year to Mar 2016.Quarterly results

Quarter to Jun 2019, against the quarter beforeFiled 13 Aug

Revenue: ₹1.19 Crup 101.67%
Net profit: −₹7.54 CrQuarter to Mar 2019: −₹11 Cr
Net margin: −636.4%

Revenue by year

Net profit by year, a loss in red

Net profit
Loss

A loss in 3 of the 4 years with results on record

The years either side of a change of basis do not compare. From the year to Mar 2016, part of the business was demerged on 21 Sep 2015, and figures before the change include the part that left.

₹ crore	Sep 2017	Dec 2017	Mar 2018	Jun 2018Filed 18 Aug	Sep 2018Filed 26 Nov	Dec 2018Filed 13 Feb	Mar 2019Filed 7 Jun	Jun 2019Filed 13 Aug
Revenue	4.7	3.9	−0.5	1.3	1.5	1.6	0.6	1.2
Net profit	−2.6	−5.6	−4.9	−4.3	−5.7	−0.6	−11.3	−7.5
Net margin	−54.3%	−144.9%	963.3%	−330.4%	−374.3%	−41.0%	−1,922.5%	−636.4%

Standalone. The last eight quarters. The latest is shaded.

Business segments

In the year to Mar 2019 the company reports one business segment, AGRI BIOTECH PRODUCTS, which carries all its revenue.

Where the return came from

Yearly rates to Mar 2019, per-share figures restated for splits and bonuses.

Over	Return a year	Earnings growth	Change in P/E	Dividend yield
1 year	−54.5%	–	–	0.0%
3 years	−41.8%	–	–	0.0%

Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.

Camson Bio Technologies share price by year

Each calendar year to 2020.

Year	Close at year end	Change	Highest close	Lowest close
2020	3.31	−26.0%	4.39	3.31
2019	4.47	−51.9%	13.79	4.47
2018	9.30	−62.0%	25.35	4.81
2017	24.50	−4.9%	33.50	16.00
2016	25.75	−39.1%	61.50	18.70
2015	42.25	–	132.40	38.85

₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2020 close is its last trade, on 11 May 2020.

Recent sessions

The last 10 trading days to 11 May 2020, as traded on BSE.

Date	Open	High	Low	Close	Average price	Volume
11 May 2020	3.31	3.31	3.31	3.31	3.31	1,760
4 May 2020	3.37	3.37	3.37	3.37	3.37	261
20 Apr 2020	3.43	3.43	3.43	3.43	3.43	1,382
13 Apr 2020	3.50	3.50	3.50	3.50	3.50	1,100
7 Apr 2020	3.57	3.57	3.57	3.57	3.57	1,650
30 Mar 2020	3.71	3.71	3.64	3.64	3.69	894
16 Mar 2020	3.71	3.71	3.71	3.71	3.71	18,000
9 Mar 2020	3.78	3.78	3.78	3.78	3.78	66
2 Mar 2020	3.85	3.85	3.85	3.85	3.85	30,218
24 Feb 2020	3.99	3.99	3.92	3.92	3.99	303

Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.Demerger history

Ex-date	Event	Price factor	What happened
21 Sep 2015	Demerger	0.9815	Part of the business became a separate company. The factor is the opening price on the ex-date divided by the previous close. The chart shows earlier prices with the demerger reinvested.

Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.

Company details

Legal name: Camson Bio Technologies Ltd
BSE code: 538858
ISIN: INE845E01012
Industry: Pharmaceuticals & Biotechnology
Listed: Jan 2015
Face value: ₹10
Website: www.camsonbiotechnologies.com (opens in a new tab)
CIN: L85110KA1993PLC014944; Corporate identity number, the registrar of companies' code for it

Latest announcements

Jan 2021

Feb 2020

Nov 2019

Oct 2019

Share price history